Tadeusz Goralczyk

Measurement of apixaban concentrations in real‑world clinical and laboratory settings: the first Polish experience.

Journal: Polish archives of internal medicine

Published: May 17, 2018

Viscoelastic properties of plasma fibrin clots are similar in patients on rivaroxaban and vitamin K antagonists.

Journal: Journal of physiology and pharmacology : an official journal of the Polish Physiological Society

Published: February 01, 2018

Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery.

Journal: Journal of thrombosis and thrombolysis

Published: December 10, 2017

Non-vitamin K antagonist oral anticoagulants in patients with severe inherited thrombophilia: a series of 33 patients.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: January 13, 2017

Direct Oral Anticoagulants in Patients with Thrombophilia: Challenges in Diagnostic Evaluation and Treatment.

Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University

Published: September 20, 2016

Activated protein C resistance in patients following venous thromboembolism receiving rivaroxaban versus vitamin K antagonists: assessment using Russell viper venom time-based assay.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: September 17, 2016

The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.

Journal: Thrombosis research

Published: July 30, 2016

False-positive lupus anticoagulant in patients receiving rivaroxaban: 24 h since the last dose are needed to exclude antiphospholipid syndrome.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: November 18, 2014

Rivaroxaban concentration in patients with deep vein thrombosis who reported thrombus progression or minor hemorrhagic complications: first Polish experience.

Journal: Polskie Archiwum Medycyny Wewnetrznej

Published: October 15, 2014

Measurement of apixaban concentrations in real‑world clinical and laboratory settings: the first Polish experience.

Measurement of apixaban concentrations in real‑world clinical and laboratory settings: the first Polish experience.

Viscoelastic properties of plasma fibrin clots are similar in patients on rivaroxaban and vitamin K antagonists.

Viscoelastic properties of plasma fibrin clots are similar in patients on rivaroxaban and vitamin K antagonists.

Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery.

Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery.

Non-vitamin K antagonist oral anticoagulants in patients with severe inherited thrombophilia: a series of 33 patients.

Non-vitamin K antagonist oral anticoagulants in patients with severe inherited thrombophilia: a series of 33 patients.

Direct Oral Anticoagulants in Patients with Thrombophilia: Challenges in Diagnostic Evaluation and Treatment.

Direct Oral Anticoagulants in Patients with Thrombophilia: Challenges in Diagnostic Evaluation and Treatment.

Activated protein C resistance in patients following venous thromboembolism receiving rivaroxaban versus vitamin K antagonists: assessment using Russell viper venom time-based assay.

Activated protein C resistance in patients following venous thromboembolism receiving rivaroxaban versus vitamin K antagonists: assessment using Russell viper venom time-based assay.

The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.

The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.

False-positive lupus anticoagulant in patients receiving rivaroxaban: 24 h since the last dose are needed to exclude antiphospholipid syndrome.

False-positive lupus anticoagulant in patients receiving rivaroxaban: 24 h since the last dose are needed to exclude antiphospholipid syndrome.

Rivaroxaban concentration in patients with deep vein thrombosis who reported thrombus progression or minor hemorrhagic complications: first Polish experience.

Rivaroxaban concentration in patients with deep vein thrombosis who reported thrombus progression or minor hemorrhagic complications: first Polish experience.

Monitoring of anticoagulant effects of dabigatran in everyday practice: first experience in 32 Polish patients.

Monitoring of anticoagulant effects of dabigatran in everyday practice: first experience in 32 Polish patients.

Acquired factor V inhibitor in a woman following aortic aneurysm surgery.

Acquired factor V inhibitor in a woman following aortic aneurysm surgery.

Nonstenotic bicuspid aortic valve is associated with elevated plasma asymmetric dimethylarginine.

Nonstenotic bicuspid aortic valve is associated with elevated plasma asymmetric dimethylarginine.